Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Neuralink Gets Green Light From FDA to Accelerate Speech-Restoring Tech

Daniel Kim Views  

Shutterstock
Shutterstock

The US Food and Drug Administration (FDA) grants “breakthrough approval” to the Neuralink device.

On social media, Neuralink recently revealed that the FDA had awarded its medical device a “breakthrough tag” for helping individuals with severe speech impairments regain communication.

People with multiple sclerosis, cerebral palsy, spinal cord injury, stroke, amyotrophic lateral sclerosis (ALS), and other neurological disorders should benefit from Neuralink’s device.

Patients and healthcare professionals can use new medical devices sooner thanks to the US FDA’s “breakthrough devices program,” which expedites developing, assessing, and reviewing medical devices.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[LIFESTYLE] Latest Stories

  • Sitting Too Long? Your Brain Might Be Paying the Price
  • Lemon Water’s Glow-Up: 7 Easy Add-Ins That Make It Healthier (and Tastier)
  • Cutting Fat May Help Cut the Blues, New Study Says
  • Sitting Too Much Could Kill You, Even After a Heart Scare, Study Says
  • Oral Probiotics Are Trending — But Are They the Real Deal?
  • Love Carbs? This Simple Trick Makes Rice and Pasta Healthier

Share it on...